Absci/$ABSI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Absci
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
Ticker
$ABSI
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
157
ISIN
US00091E1091
Website
Absci Metrics
BasicAdvanced
$348M
-
-$0.92
2.20
-
Price and volume
Market cap
$348M
Beta
2.2
52-week high
$6.33
52-week low
$2.01
Average daily volume
2.6M
Financial strength
Current ratio
5.717
Quick ratio
4.962
Long term debt to equity
2.357
Total debt to equity
4.486
Interest coverage (TTM)
-238.72%
Management effectiveness
Return on assets (TTM)
-27.53%
Return on equity (TTM)
-48.98%
Valuation
Price to revenue (TTM)
66.057
Price to book
1.75
Price to tangible book (TTM)
2.25
Price to free cash flow (TTM)
-4.141
Growth
Revenue change (TTM)
-9.95%
Earnings per share change (TTM)
-20.58%
3-year revenue growth (CAGR)
1.99%
3-year earnings per share growth (CAGR)
-19.64%
What the Analysts think about Absci
Analyst ratings (Buy, Hold, Sell) for Absci stock.
Absci Financial Performance
Revenues and expenses
Absci Earnings Performance
Company profitability
Absci News
AllArticlesVideos
Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript
Seeking Alpha·3 weeks ago
Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results
GlobeNewsWire·3 weeks ago
Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Absci stock?
Absci (ABSI) has a market cap of $348M as of June 04, 2025.
What is the P/E ratio for Absci stock?
The price to earnings (P/E) ratio for Absci (ABSI) stock is 0 as of June 04, 2025.
Does Absci stock pay dividends?
No, Absci (ABSI) stock does not pay dividends to its shareholders as of June 04, 2025.
When is the next Absci dividend payment date?
Absci (ABSI) stock does not pay dividends to its shareholders.
What is the beta indicator for Absci?
Absci (ABSI) has a beta rating of 2.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.